246 related articles for article (PubMed ID: 18713990)
1. OX40/OX40L costimulation affects induction of Foxp3+ regulatory T cells in part by expanding memory T cells in vivo.
Xiao X; Kroemer A; Gao W; Ishii N; Demirci G; Li XC
J Immunol; 2008 Sep; 181(5):3193-201. PubMed ID: 18713990
[TBL] [Abstract][Full Text] [Related]
2. OX40 costimulation turns off Foxp3+ Tregs.
Vu MD; Xiao X; Gao W; Degauque N; Chen M; Kroemer A; Killeen N; Ishii N; Li XC
Blood; 2007 Oct; 110(7):2501-10. PubMed ID: 17575071
[TBL] [Abstract][Full Text] [Related]
3. OX40 controls functionally different T cell subsets and their resistance to depletion therapy.
Kroemer A; Xiao X; Vu MD; Gao W; Minamimura K; Chen M; Maki T; Li XC
J Immunol; 2007 Oct; 179(8):5584-91. PubMed ID: 17911646
[TBL] [Abstract][Full Text] [Related]
4. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
[TBL] [Abstract][Full Text] [Related]
5. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology.
Ishii N; Takahashi T; Soroosh P; Sugamura K
Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730
[TBL] [Abstract][Full Text] [Related]
6. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
Kitamura N; Murata S; Ueki T; Mekata E; Reilly RT; Jaffee EM; Tani T
Int J Cancer; 2009 Aug; 125(3):630-8. PubMed ID: 19455675
[TBL] [Abstract][Full Text] [Related]
7. Soluble OX40L and JAG1 Induce Selective Proliferation of Functional Regulatory T-Cells Independent of canonical TCR signaling.
Kumar P; Alharshawi K; Bhattacharya P; Marinelarena A; Haddad C; Sun Z; Chiba S; Epstein AL; Prabhakar BS
Sci Rep; 2017 Jan; 7():39751. PubMed ID: 28045060
[TBL] [Abstract][Full Text] [Related]
8. OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential.
Lai C; August S; Albibas A; Behar R; Cho SY; Polak ME; Theaker J; MacLeod AS; French RR; Glennie MJ; Al-Shamkhani A; Healy E
Clin Cancer Res; 2016 Aug; 22(16):4236-48. PubMed ID: 27034329
[TBL] [Abstract][Full Text] [Related]
9. OX40 and IL-7 play synergistic roles in the homeostatic proliferation of effector memory CD4⁺ T cells.
Yamaki S; Ine S; Kawabe T; Okuyama Y; Suzuki N; Soroosh P; Mousavi SF; Nagashima H; Sun SL; So T; Sasaki T; Harigae H; Sugamura K; Kudo H; Wada M; Nio M; Ishii N
Eur J Immunol; 2014 Oct; 44(10):3015-25. PubMed ID: 25103720
[TBL] [Abstract][Full Text] [Related]
10. OX40 is required for regulatory T cell-mediated control of colitis.
Griseri T; Asquith M; Thompson C; Powrie F
J Exp Med; 2010 Apr; 207(4):699-709. PubMed ID: 20368580
[TBL] [Abstract][Full Text] [Related]
11. OX40L/OX40 axis impairs follicular and natural Treg function in human SLE.
Jacquemin C; Augusto JF; Scherlinger M; Gensous N; Forcade E; Douchet I; Levionnois E; Richez C; Lazaro E; Duffau P; Truchetet ME; Seneschal J; Couzi L; Pellegrin JL; Viallard JF; Schaeverbeke T; Pascual V; Contin-Bordes C; Blanco P
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568041
[TBL] [Abstract][Full Text] [Related]
12. OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms.
Zhang X; Xiao X; Lan P; Li J; Dou Y; Chen W; Ishii N; Chen S; Xia B; Chen K; Taparowsky E; Li XC
Cell Rep; 2018 Jul; 24(3):607-618. PubMed ID: 30021159
[TBL] [Abstract][Full Text] [Related]
13. OX40 ligand is inhibitory during the effector phase of crescentic glomerulonephritis.
Odobasic D; Ruth AJ; Oudin V; Kitching AR; Holdsworth SR
Nephrol Dial Transplant; 2019 Mar; 34(3):429-441. PubMed ID: 29939347
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment.
Bresson D; Fousteri G; Manenkova Y; Croft M; von Herrath M
J Autoimmun; 2011 Dec; 37(4):342-51. PubMed ID: 22063316
[TBL] [Abstract][Full Text] [Related]
15. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.
Xiao X; Gong W; Demirci G; Liu W; Spoerl S; Chu X; Bishop DK; Turka LA; Li XC
J Immunol; 2012 Jan; 188(2):892-901. PubMed ID: 22147766
[TBL] [Abstract][Full Text] [Related]
16. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.
Alharshawi K; Marinelarena A; Kumar P; El-Sayed O; Bhattacharya P; Sun Z; Epstein AL; Maker AV; Prabhakar BS
Sci Rep; 2017 Jul; 7(1):6594. PubMed ID: 28747670
[TBL] [Abstract][Full Text] [Related]
17. Critical role of OX40 signaling in the TCR-independent phase of human and murine thymic Treg generation.
Kumar P; Marinelarena A; Raghunathan D; Ragothaman VK; Saini S; Bhattacharya P; Fan J; Epstein AL; Maker AV; Prabhakar BS
Cell Mol Immunol; 2019 Feb; 16(2):138-153. PubMed ID: 29578532
[TBL] [Abstract][Full Text] [Related]
18. The role of OX40-mediated co-stimulation in T-cell activation and survival.
Redmond WL; Ruby CE; Weinberg AD
Crit Rev Immunol; 2009; 29(3):187-201. PubMed ID: 19538134
[TBL] [Abstract][Full Text] [Related]
19. OX40, OX40L and Autoimmunity: a Comprehensive Review.
Webb GJ; Hirschfield GM; Lane PJ
Clin Rev Allergy Immunol; 2016 Jun; 50(3):312-32. PubMed ID: 26215166
[TBL] [Abstract][Full Text] [Related]
20. CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.
St Rose MC; Taylor RA; Bandyopadhyay S; Qui HZ; Hagymasi AT; Vella AT; Adler AJ
Immunol Cell Biol; 2013 Feb; 91(2):173-83. PubMed ID: 23295363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
